Patricia Martin's most recent trade in Par Pacific Holdings Inc was a trade of 795 Common stock done at an average price of $31.5 . Disclosure was reported to the exchange on July 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Par Pacific Holdings Inc | Patricia Martinez | Director | Grant, award, or other acquisition of securities at price $ 31.45 per share. | 05 Jul 2025 | 795 | 9,607 (0%) | 0% | 31.5 | 25,003 | Common stock |
| AN2 Therapeutics Inc | Patricia Martin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 19,111 | 19,111 | - | - | Stock Option (Right to Buy) | |
| NOV Inc | Patricia Martinez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2025 | 15,949 | 25,499 (0%) | 0% | 0 | Common Stock | |
| AN2 Therapeutics Inc | Patricia Martin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2025 | 3,065 | 6,231 | - | 0 | Common Stock | |
| Par Pacific Holdings Inc | Patricia Martinez | Director | Grant, award, or other acquisition of securities at price $ 12.92 per share. | 05 Apr 2025 | 1,935 | 8,812 (0%) | 0% | 12.9 | 25,000 | Common stock |
| AN2 Therapeutics Inc | Patricia Martin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2024 | 3,166 | 3,166 | - | 0 | Common Stock | |
| Par Pacific Holdings Inc | Patricia Martinez | Director | Grant, award, or other acquisition of securities at price $ 18.97 per share. | 05 Oct 2024 | 1,318 | 5,380 (0%) | 0% | 19.0 | 25,002 | Common stock |
| Leap Therapeutics Inc | Patricia Martin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2024 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Par Pacific Holdings Inc | Patricia Martinez | Director | Grant, award, or other acquisition of securities at price $ 24.62 per share. | 05 Jul 2024 | 1,015 | 4,062 (0%) | 0% | 24.6 | 24,989 | Common stock |
| AN2 Therapeutics Inc | Patricia Martin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2024 | 64,503 | 64,503 | - | - | Stock Option (Right to Buy) | |
| NOV Inc | Patricia Martinez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 9,550 | 9,550 (0%) | 0% | 0 | Common Stock | |
| Par Pacific Holdings Inc | Patricia Martinez | Director | Grant, award, or other acquisition of securities at price $ 39.49 per share. | 05 Apr 2024 | 633 | 3,047 (0%) | 0% | 39.5 | 24,997 | Common stock |
| Leap Therapeutics Inc | Patricia Martin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Par Pacific Holdings Inc | Patricia Martinez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 721 | 2,414 (0%) | 0% | 0 | Common Stock | |
| Par Pacific Holdings Inc | Patricia Martinez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2023 | 770 | 1,693 (0%) | 0% | 0 | Common stock | |
| Leap Therapeutics Inc | Patricia Martin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2023 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Par Pacific Holdings Inc | Patricia Martinez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2023 | 923 | 923 (0%) | 0% | 0 | Common stock | |
| Leap Therapeutics Inc | Patricia Martin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| AN2 Therapeutics Inc | Patricia Martin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2022 | 10,362 | 10,362 | - | - | Stock Option (right to buy) |